ADAM SHAPIRO: Open Payments
NPI 1457738825 · GREENWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 10 payments from 4 companies in 2025. Trend: 2023 $67 · 2024 $180 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $376 |
| E.R. Squibb & Sons, L.L.C. | 2 | $175 |
| ABBVIE INC. | 1 | $130 |
| GlaxoSmithKline, LLC. | 4 | $96 |
Products named: CAPLYTA, COBENFY, VRAYLAR, SHINGRIX.
Industry payments across CT — which companies pay providers there.
